SAP's stock plunge deepens as security flaws and cloud slowdown rattle investors
SAP is facing growing challenges as its share price tumbles and analysts cut expectations. The German software giant, once a market favourite, has seen its value drop sharply in 2026 due to security concerns and weaker-than-expected cloud growth. Investors are now watching closely ahead of its first-quarter results.
The company's troubles began with the discovery of two serious security flaws in its enterprise systems. These vulnerabilities shook customer trust and contributed to a steep decline in SAP's stock. By March 13, 2026, shares had fallen to €165.74—near a 52-week low—despite strong 2025 financials, including a 23% rise in cloud revenue to €21 billion.
Analysts have responded by lowering their targets. BMO Capital reduced its price forecast from $320 to $245, while Barclays cut its target from $348 to $283. Zacks Research also downgraded SAP from Strong Buy to Hold. These adjustments reflect concerns over missed cloud backlog targets and fading momentum.
Year-to-date losses for shareholders now stand at nearly 29%. The company's market capitalisation has slipped to around €193-194 billion, down from higher levels suggested by its 2025 share price of €167. Despite these setbacks, SAP continues its €10 billion share buyback programme, and its AI assistant, Joule, remains active in over 210 global use cases.
The next key moment for SAP arrives on April 23, 2026, with the release of its first-quarter earnings. Investors will be looking for signs of recovery or further pressure on growth.
SAP's stock has taken a hit from security issues and slower cloud expansion. With analysts lowering expectations and shareholders facing losses, the upcoming earnings report will be critical. The company's ability to address these challenges could determine whether confidence rebounds or declines further.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.